rhEPO

DRUG7 trials

Conditions

AnaemiaAspergillosis, Allergic BronchopulmonaryCardiac SurgeryChemotherapy-induced AnemiaNon-myeloid Malignancies

Phase 2

4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease

Start: 2012-05-23End: 2013-05-27Updated: 2017-11-14

Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia

CompletedNCT01977482

GlaxoSmithKlineAnaemia

Start: 2013-11-01End: 2015-02-06Updated: 2018-06-08

A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)

CompletedNCT01977573

GlaxoSmithKlineAnaemia

Start: 2013-10-31End: 2015-06-15Updated: 2018-10-12

Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)

CompletedNCT03457701

GlaxoSmithKlineAnaemia

Start: 2019-07-30End: 2022-07-05Updated: 2024-03-27

Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies

Not yet recruitingNCT06854276

Shenyang Sunshine Pharmaceutical Co., LTD.Chemotherapy-induced Anemia, Non-myeloid Malignancies

Start: 2025-03-01End: 2027-12-01Target: 80Updated: 2025-03-03

Phase 3

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

CompletedNCT02879305

GlaxoSmithKlineAnaemia, Aspergillosis, Allergic Bronchopulmonary

Start: 2016-09-28End: 2020-11-09Updated: 2021-12-03

Unknown Phase

Effect of Preoperative Recombinant Human Erythropoietin on Transfusion Risk in Valvular Heart Surgery

CompletedNCT00939978

Yonsei UniversityCardiac Surgery

Start: 2009-04-30End: 2010-07-31Updated: 2010-10-07

Kidney3602025-05-071 citations

Efficacy and safety of daprodustat in patients on peritoneal dialysis in the ASCEND-D trial

Nephrology Dialysis Transplantation2024-11-21

#3807 HEART FAILURE IN ASCEND-ND AND ASCEND-D

Nephrology Dialysis Transplantation2023-06-01

#3715 THE EFFECT OF DAPRODUSTAT ON INTRAVENOUS IRON USE IN PATIENTS WITH CKD-RELATED ANAEMIA ON DIALYSIS IN THE ASCEND TRIALS

Nephrology Dialysis Transplantation2023-06-01

Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)

American Journal of Nephrology2023-01-0111 citations

Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents—<i>post hoc</i> analyses of the ASCEND-ND and ASCEND-D trials

Nephrology Dialysis Transplantation2022-12-2410 citations

Causes of death in patients with chronic kidney disease: insights from the ASCEND-D and ASCEND-ND cardiovascular outcomes trials

European Heart Journal2022-10-018 citations

Efficacité du daprodustat sur le taux d’Hb et sécurité cardiovasculaire dans les études ASCEND-ND, -D, et -ID

Néphrologie & Thérapeutique2022-09-01

MO530: Daprodustat is not Associated With an Increased Risk of Cancer: Results From the ASCEND-D and ASCEND-ND Trials

Nephrology Dialysis Transplantation2022-05-012 citations

Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis

New England Journal of Medicine2021-11-05220 citations

Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial

Nephrology Dialysis Transplantation2021-03-1817 citations

P0862DAPRODUSTAT INTERACTION WITH PHOSPHATE BINDERS HAS MINIMAL IMPACT ON HEMOGLOBIN VALUES IN HEMODIALYSIS POPULATION

Nephrology Dialysis Transplantation2020-06-011 citations

A randomized, 29-day, dose-ranging, efficacy and safety study of daprodustat, administered three times weekly in patients with anemia on hemodialysis

BMC Nephrology2019-10-1634 citations

rhEPO

Sponsors

Conditions

Phase 2

Phase 3

Unknown Phase

Related Papers